Showing results (161-170 of 226) with videos related to
Sort By:
Pageof 23
Haematologica|July 5, 2006
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overloadAntonio Piga, Renzo Galanello, Gian Luca Forni, et al.Elife|September 14, 2021
Translational control of polyamine metabolism by CNBP is required for <i>Drosophila</i> locomotor functionSonia Coni, Federica A Falconio, Marta Marzullo, et al.Cell Death Discovery|December 18, 2024
SMURF1 and SMURF2 directly target GLI1 for ubiquitination and proteasome-dependent degradationFabio Bordin, Gloria Terriaca, Adriano Apostolico, et al.Lung Cancer (Amsterdam, Netherlands)|May 15, 2020
Real-world assessment of the BRAF status in non-squamous cell lung carcinoma using VE1 immunohistochemistry: A single laboratory experience (LPCE, Nice, France)Véronique Hofman, Jonathan Benzaquen, Simon Heeke, et al.JAMA|November 12, 2009
Prone positioning in patients with moderate and severe acute respiratory distress syndrome: a randomized controlled trialPaolo Taccone, Antonio Pesenti, Roberto Latini, et al.Journal of the American Academy of Dermatology|October 18, 2024
Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trialMelissa Piliang, Charles Lynde, Brett King, et al.Cancers|May 14, 2022
Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)Marius Ilié, Véronique Hofman, Christophe Bontoux, et al.Cancers|April 17, 2020
Targeted Assessment of the <i>EGFR</i> Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)Sandra Lassalle, Véronique Hofman, Simon Heeke, et al.Oncotarget|December 15, 2018
Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patientsElodie Long-Mira, Marius Ilie, Emmanuel Chamorey, et al.The American Journal of Pathology|April 4, 2009
Gab2-mediated signaling promotes melanoma metastasisBasil Horst, Sofia K Gruvberger-Saal, Benjamin D Hopkins, et al.Pageof 23